JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.57B |
| 2 |
Amazon
AMZN
|
+$2.84B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.47B |
| 4 |
Mastercard
MA
|
+$1.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.31B |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$4.44B |
| 2 |
Apple
AAPL
|
+$3.14B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.87B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.84B |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$1.57B |
Sector Composition
| 1 | Technology | 20.05% |
| 2 | Healthcare | 11.18% |
| 3 | Financials | 9.56% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Industrials | 7.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FREE
2926
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $1.72M | ﹤0.01% |
476,598
+46,332
| +11% | +$167K |
|
2927
Leonardo DRS
DRS
$11.2B
| $1.72M | ﹤0.01% |
102,732
+31,063
| +43% | +$519K |
|
2928
Nuveen ESG Small-Cap ETF
NUSC
$1.21B
| $1.71M | ﹤0.01% |
49,126
+70
| +0.1% | +$2.44K |
|
2929
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$588M
| $1.71M | ﹤0.01% |
53,214
+15,876
| +43% | +$510K |
|
2930
TG Therapeutics
TGTX
$5.14B
| $1.71M | ﹤0.01% |
204,550
-70,420
| -26% | -$589K |
|
2931
Smith & Wesson
SWBI
$413M
| $1.71M | ﹤0.01% |
132,179
-17,618
| -12% | -$227K |
|
2932
Martin Midstream Partners
MMLP
$121M
| $1.7M | ﹤0.01% |
613,215
+54,616
| +10% | +$152K |
|
2933
OrthoPediatrics
KIDS
$493M
| $1.7M | ﹤0.01% |
53,239
-3,989
| -7% | -$128K |
|
2934
HSBC
HSBC
$240B
| $1.7M | ﹤0.01% |
43,167
-112,002
| -72% | -$4.42M |
|
2935
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.15B
| $1.7M | ﹤0.01% |
26,245
+187
| +0.7% | +$12.1K |
|
2936
OraSure Technologies
OSUR
$244M
| $1.7M | ﹤0.01% |
286,040
+116,064
| +68% | +$688K |
|
2937
Telkom Indonesia
TLK
$19.4B
| $1.69M | ﹤0.01% |
70,283
+2,838
| +4% | +$68.4K |
|
2938
Keros Therapeutics
KROS
$647M
| $1.69M | ﹤0.01% |
53,069
+23,379
| +79% | +$745K |
|
2939
Lucid Motors
LCID
$6.34B
| $1.69M | ﹤0.01% |
30,234
-7,099
| -19% | -$397K |
|
2940
Park National Corp
PRK
$2.73B
| $1.69M | ﹤0.01% |
17,861
-6,726
| -27% | -$636K |
|
2941
iShares US Financials ETF
IYF
$4.1B
| $1.69M | ﹤0.01% |
22,572
-210
| -0.9% | -$15.7K |
|
2942
Sapiens International
SPNS
$2.4B
| $1.69M | ﹤0.01% |
59,340
-4,080
| -6% | -$116K |
|
2943
Caleres
CAL
$506M
| $1.69M | ﹤0.01% |
58,627
-6,797
| -10% | -$195K |
|
2944
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.15B
| $1.68M | ﹤0.01% |
39,038
+7,481
| +24% | +$323K |
|
2945
Ubiquiti
UI
$37.7B
| $1.68M | ﹤0.01% |
11,569
-4,536
| -28% | -$659K |
|
2946
IDT Corp
IDT
$1.7B
| $1.68M | ﹤0.01% |
76,100
+4,526
| +6% | +$99.8K |
|
|
OPI
2947
Office Properties Income Trust
OPI
$34.4M
| $1.67M | ﹤0.01% |
406,340
+270,741
| +200% | +$1.11M |
|
2948
Amylyx Pharmaceuticals
AMLX
$1.39B
| $1.67M | ﹤0.01% |
90,965
-99,331
| -52% | -$1.82M |
|
2949
Hartford Core Bond ETF
HCRB
$348M
| $1.66M | ﹤0.01% |
+50,061
| New | +$1.66M |
|
|
INVX
2950
Innovex International, Inc.
INVX
$1.18B
| $1.66M | ﹤0.01% |
58,992
+10,830
| +22% | +$305K |
|